REGENXBIO Inc. Annual Operating Income (Loss) in USD from 2013 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
REGENXBIO Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
- REGENXBIO Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$56M, a 23.4% increase year-over-year.
- REGENXBIO Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$249M, a 7.21% increase year-over-year.
- REGENXBIO Inc. annual Operating Income (Loss) for 2023 was -$268M, a 2% decline from 2022.
- REGENXBIO Inc. annual Operating Income (Loss) for 2022 was -$263M, a 264% decline from 2021.
- REGENXBIO Inc. annual Operating Income (Loss) for 2021 was $160M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)